H7N9 influenza virus split vaccine (Sinovac Biotech)

甲型H7N9流感病毒裂解疫苗（科兴生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N9 influenza virus split vaccine (Sinovac Biotech)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza A virus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (IND)

Highest Status in ChinaPending

Originator CompaniesSinovac Biotech Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesSinovac Biotech Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza A virus infections

Other Information

ATC CodeN/A